SEC Form 4 · accession 0001993684-26-000008
Immunome Inc. · IMNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Higgins
Officer — Chief Scientific Officer
Period of report
Sep 11, 2026
Accepted (ET)
Sep 15, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001472012
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2026 | M | 18,000 | $1.35 | A | 78,250 | D | |
| Common Stock | Sep 11, 2026 | S | 13,200 | $25.32 | D | 65,050 | D | |
| Common Stock | Sep 11, 2026 | G | 8,800 | $0.00 | D | 56,250 | D | |
| Common StockF2 | holding | — | — | — | 1,000 | I | As Custodian for Child 1 | |
| Common StockF2 | holding | — | — | — | 1,000 | I | As Custodian for Child 2 | |
| Common StockF2 | holding | — | — | — | 1,000 | I | As Custodian for Child 3 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $1.35 | Sep 11, 2026 | M | 18,000 | A | — | Jun 23, 2032 | Common Stock | 18,000 | 133,840 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
- F2The Reporting Person serves as a custodian of a custodial account for his child pursuant to the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.
- F325% of the shares subject to the options vested on May 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options vests every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.